Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In vivo assessment of differential toxicity of cancer treatment drugs in Fanconi’s Anemia

In vivo assessment of differential toxicity of cancer treatment drugs in Fanconi’s Anemia is a research paper. On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (9)IDs (PubMed, OpenAlex)

Context only (not used in score)

Findable (1/2)

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

We only score data papers we can read in full — never from an abstract alone.

Sebastian Cruz-Gomez,Allison MacMillan,Alexander Peters,Barbara Burtness ORCID,Markus Grompe ORCID

Live enrichment

Stand up to Cancer Foundation

Fanconi Anemia Cancer Fund

greenLicense: cc-by-nc-nd

Fields of Study

DNA Repair MechanismsCancer therapeutics and mechanismsCarcinogens and Genotoxicity Assessment

Keywords

ToxicityChemotherapyFanconi anemiaIn vivoCancerHaematopoiesis